Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice

Figure 9

Schematic representative hypothesis for the mechanisms of the inhibition of the progressive of chronic kidney disease (CKD) by chronic elafibranor treatment on HFD mice with steatohepatitis in our study.